1 |
Dadi BR, Abebe T, Zhang L, Mihret A, Abebe W, Amogne W. Distribution of virulence genes and phylogenetics of uropathogenic Escherichia coli among urinary tract infection patients in Addis Ababa, Ethiopia. BMC Infect Dis. 2020;20:108. https://doi.org/10.1186/s12879-020-4844-z
DOI
|
2 |
Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol. 2010;7:653-660. https://doi.org/10.1038/nrurol.2010.190
DOI
|
3 |
Hooton TM. Recurrent urinary tract infection in women. Int J Antimicrob Agents. 2001;17:259-268. https://doi.org/10.1016/s0924-8579(00)00350-2
DOI
|
4 |
Foxman B. Recurring urinary tract infection: incidence and risk factors. Am J Public Health. 1990;80:331-333. https://doi.org/10.2105/ajph.80.3.331
DOI
|
5 |
Norouzian H, Katouli M, Shahrokhi N, Sabeti S, Pooya M, Bouzari S. The relationship between phylogenetic groups and antibiotic susceptibility patterns of Escherichia coli strains isolated from feces and urine of patients with acute or recurrent urinary tract infection. Iran J Microbiol. 2019;11:478-487.
|
6 |
Loh K, Sivalingam N. Urinary tract infections in pregnancy. Malays Fam Physician. 2007;2:54-57.
|
7 |
Schwartz DJ1, Kalas V, Pinkner JS, Chen SL, Spaulding CN, Dodson KW, et al. Positively selected FimH residues enhance virulence during urinary tract infection by altering FimH conformation. Proc Natl Acad Sci U S A. 2013;110:15530-15537. https://doi.org/10.1073/pnas.1315203110
DOI
|
8 |
Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med. 2002;113:14S-19S. https://doi.org/10.1016/s0002-9343(02)01055-0
DOI
|
9 |
Zowawi HM, Harris PN, Roberts MJ, Tambyah PA, Schembri MA, Pezzani MD, et al. The emerging threat of multidrug-resistant Gram-negative bacteria in urology. Nat Rev Urol. 2015;12:570-584. https://doi.org/10.1038/nrurol.2015.199
DOI
|
10 |
Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268-281. https://doi.org/10.1111/j.1469-0691.2011.03570.x
DOI
|
11 |
Alghoribi MF, Gibreel TM, Farnham G, Al Johani SM, Balkhy HH, Upton M. Antibiotic-resistant ST38, ST131 and ST405 strains are the leading uropathogenic Escherichia coli clones in Riyadh, Saudi Arabia. J Antimicrob Chemother. 2015;70:2757-2762. https://doi.org/10.1093/jac/dkv188
DOI
|
12 |
Nicolas-Chanoine MH, Bertrand X, Madec JY. Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev. 2014;27:543-574. https://doi.org/10.1128/CMR.00125-13
DOI
|
13 |
Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, Canica MM, et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother. 2008;61:273-281. https://doi.org/10.1093/jac/dkm464
DOI
|
14 |
Peirano G, Pitout JD. Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents. 2010;35:316-321. https://doi.org/10.1016/j.ijantimicag.2009.11.003
DOI
|
15 |
Alqasim A, Abu Jaffal A, Alyousef AA. Prevalence and molecular characteristics of sequence type 131 clone among clinical uropathogenic Escherichia coli isolates in Riyadh, Saudi Arabia. Saudi J Biol Sci. 2020;27:296-302. https://doi.org/10.1016/j.sjbs.2019.09.020
DOI
|
16 |
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twentieth informational supplement, M100-S20. Wayne, PA: Clinical and Laboratory Standards Institute; 2010.
|
17 |
Cheung DA, Nicholson A, Butterfield TR, da Costa M. Prevalence, co-infection and antibiotic resistance of Escherichia Coli from blood and urine samples at a hospital in Jamaica. J Infect Dev Ctries. 2020;14:146-152. https://doi.org/10.3855/jidc.11361
DOI
|
18 |
Mortazavi-Tabatabaei SAR, Ghaderkhani J, Nazari A, Sayehmiri K, Sayehmiri F, Pakzad I. Pattern of antibacterial resistance in urinary tract infections: A systematic review and meta-analysis. Int J Prev Med. 2019;10:169. https://doi.org/10.4103/ijpvm.IJPVM_419_17
DOI
|
19 |
Kothari A, Sagar V. Antibiotic resistance in pathogens causing community-acquired urinary tract infections in India: A multicenter study. J Infect Dev Ctries. 2008;2:354-358. https://doi.org/10.3855/jidc.196
DOI
|
20 |
Matsui Y, Hu Y, Rubin J, de Assis RS, Suh J, Riley LW. Multilocus sequence typing of Escherichia coli isolates from urinary tract infection patients and from fecal samples of healthy subjects in a college community. Microbiologyopen. 2020;9:e1032. https://doi.org/10.1002/mbo3.1032
DOI
|
21 |
Goncalves LF, de Oliveira Martins-Júnior P, de Melo ABF, da Silva RCRM, de Paulo Martins V, Pitondo-Silva A, et al. Multidrug resistance dissemination by extended-spectrum β-lactamase-producing Escherichia coli causing community-acquired urinary tract infection in the Central-Western Region, Brazil. J Glob Antimicrob Resist. 2016;6:1-4. https://doi.org/10.1016/j.jgar.2016.02.003
DOI
|
22 |
da Cruz Campos AC, Cavallo FM, L Andrade N, van Dijl JM, Couto N, Zrimec J, et al. Determining the virulence properties of Escherichia coli ST131 containing bacteriocin-encoding plasmids using short- and long-read sequencing and comparing them with those of other E. coli lineages. Microorganisms. 2019;7:E534. https://doi.org/10.3390/microorganisms7110534
DOI
|
23 |
Wu J, Lan F, Lu Y, He Q, Li B. Molecular characteristics of ST1193 clone among phylogenetic group B2 non-ST131 fluoroquinolone-resistant Escherichia coli. Front Microbiol. 2017;8:2294. https://doi.org/10.3389/fmicb.2017.02294
DOI
|
24 |
Manges AR, Johnson JR, Foxman B, O'Bryan TT, Fullerton KE, Riley LW. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N Engl J Med. 2001;345:1007-1013. https://doi.org/10.1056/NEJMoa011265
DOI
|
25 |
Kim B, Seo MR, Kim J, Kim Y, Wie SH, Ki M, et al. Molecular epidemiology of ciprofloxacin-resistant Escherichia coli isolated from community-acquired urinary tract infections in Korea. Infect Chemother. 2020;52:194-203. https://doi.org/10.3947/ic.2020.52.2.194
DOI
|
26 |
Mukherjee M, Basu S, Mukherjee SK, Majumder M. Multidrug-resistance and extended spectrum beta-lactamase production in uropathogenic E. Coli which were isolated from hospitalized patients in Kolkata, India. J Clin Diagn Res. 2013;7:449-453. https://doi.org/10.7860/JCDR/2013/4990.2796
DOI
|
27 |
Iranpour D, Hassanpour M, Ansari H, Tajbakhsh S, Khamisipour G, Najafi A. Phylogenetic groups of Escherichia coli strains from patients with urinary tract infection in Iran based on the new clermont phylotyping method. Biomed Res Int. 2015;2015:846219. https://doi.org/10.1155/2015/846219
DOI
|
28 |
Plantamura J, Bousquet A, Vedy S, Larreche S, Bigaillon C, Delacour H, et al. Molecular epidemiological of extended-spectrum β-lactamase producing Escherichia coli isolated in Djibouti. Infect Dev Ctries. 2019;13:753-758. https://doi.org/10.3855/jidc.11283
DOI
|